PHASQ / PhaseBio Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

PhaseBio Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US7172241090
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier12.488.536 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

PhaseBio Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PHASQ / PhaseBio Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-08-18 Thorp Clay 10.000 3,0000 10.000 3,0000 30.000 76 4.05 10.500 35,00
2021-08-18 Hutson Nancy J 3.000 3,0800 3.000 3,0800 9.240
2020-12-03 HARRIGAN EDMUND 6.000 4,1200 6.000 4,1200 24.720
2020-11-24 Thorp Clay 2.000 3,5000 2.000 3,5000 7.000
2020-11-23 Thorp Clay 3.000 3,6700 3.000 3,6700 11.010
2018-12-17 Hutson Nancy J 1.000 4,4600 1.000 4,4600 4.460
2018-12-13 Ballance David James 1.000 3,9400 1.000 3,9400 3.940
2018-12-13 Mow Jonathan P 1.000 3,6900 1.000 3,6900 3.690
2018-12-11 York Michael 1.500 3,8800 1.500 3,8800 5.820

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PHASQ / PhaseBio Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-10-25 NEW ENTERPRISE ASSOCIATES 13 LP 1.784.109 0,1470 1.784.109 0,1470 262.264 8 0.0701 -137.198 -52,31
2021-05-20 Burkhardt Glen 3.811 3,2900 3.811 3,2900 12.538
2020-11-23 Burkhardt Glen 3.497 3,4500 3.497 3,4500 12.065

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-05-19 2023-05-19 4 Humphries William D. PHAS Common Stock M - Exercise D 2.538 2.538
2023-05-19 2023-05-19 4 Thorp Clay PHAS Common Stock M - Exercise D 3.750 36.693
2023-05-19 2023-05-19 4 van den Broek Richard PHAS Common Stock A - Award D 3.750 0
2023-05-19 2023-05-19 4 Loewy Caroline M PHAS Common Stock M - Exercise D 3.750 3.750
2023-05-19 2023-05-19 4 Sapir Alex PHAS Common Stock M - Exercise D 3.750 3.750
2023-05-19 2023-05-19 4 HARRIGAN EDMUND PHAS Common Stock M - Exercise D 3.750 9.750
2023-05-19 2023-05-19 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3.750 37.510
2022-10-26 2022-10-25 4 NEW ENTERPRISE ASSOCIATES 13 LP PHAS Common Stock S - Sale D 0,1470 -1.784.109 -262 4.857.525
2022-05-24 2022-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 0,6813 10.917 7 41.236
2022-05-24 2022-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 0,6813 10.918 7 132.502
2022-05-24 2022-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 0,6813 4.831 3 8.463
2022-05-24 2022-05-20 4 Birchall Jonathan PHAS Common Stock A - Award D 0,6813 20.000 14 20.000
2022-05-24 2022-05-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 0,7900 -11.248 -9 0
2022-05-24 2022-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 0,6813 11.248 8 11.248
2022-05-24 2022-05-20 4 Sharp John P PHAS Common Stock A - Award D 0,6813 6.026 4 65.767
2022-05-20 2021-08-18 4/A Hutson Nancy J Held in an individual retirement account for the benefit of the Reporting Person PHAS Common Stock P - Purchase I 3,0800 3.000 9 4.000
2022-05-20 2022-05-19 4 Thorp Clay PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Humphries William D. PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Sapir Alex PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 1,13 87.500 87.500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Restricted Stock Unit A - Award D 18.750 18.750
2022-02-28 2022-02-24 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 1,13 115.500 115.500
2022-02-28 2022-02-24 4 Sharp John P PHAS Restricted Stock Unit A - Award D 24.750 24.750
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 1,13 52.500 52.500
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Restricted Stock Unit A - Award D 11.250 11.250
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 1,13 87.500 87.500
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Restricted Stock Unit A - Award D 18.750 18.750
2022-02-28 2022-02-24 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 1,13 115.500 115.500
2022-02-28 2022-02-24 4 Lee John Sang PHAS Restricted Stock Unit A - Award D 24.750 24.750
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 1,13 385.000 385.000
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Restricted Stock Unit A - Award D 82.500 82.500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 1,13 87.500 87.500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Restricted Stock Unit A - Award D 18.750 18.750
2021-11-23 2021-11-19 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2,0100 2.559 5 30.319
2021-11-23 2021-11-19 4 Mow Jonathan P PHAS Common Stock A - Award D 2,0100 5.623 11 172.473
2021-11-23 2021-11-19 4 Sharp John P PHAS Common Stock A - Award D 2,0100 2.017 4 59.741
2021-11-23 2021-11-19 4 Hanson Kristopher PHAS Common Stock A - Award D 2,0100 1.545 3 3.632
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock S - Sale D 2,3700 -5.766 -14 0
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock A - Award D 2,0100 5.766 12 5.766
2021-11-09 2021-11-08 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 3,37 3,3700 250.000 842 250.000
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3,15 3,1500 -7.400 -23 0
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,1500 7.400 23 33.760
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3,15 3,1500 -1.500 -5 7.400
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 2,26 2,2600 -24.860 -56 2.256
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,1500 1.500 5 26.360
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 2,2600 24.860 56 24.860
2021-11-03 2021-11-03 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,68 1,6800 -7.500 -13 90.582
2021-11-03 2021-11-03 4 Sharp John P PHAS Common Stock M - Exercise D 1,6800 7.500 13 57.724
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 1,2400 -20.000 -25 108.767
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 20.000 25 166.850
2021-09-15 2021-09-14 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 2,80 28.000 28.000
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,74 -4.519 0
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,7400 4.519 8 27.760
2021-09-03 2021-08-03 4/A Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,68 -7.500 98.082
2021-09-03 2021-08-03 4/A Sharp John P PHAS Common Stock M - Exercise D 1,6800 7.500 13 50.224
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 -20.000 128.767
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 20.000 25 146.850
2021-08-19 2021-08-18 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 3,0800 3.000 9 4.000
2021-08-18 2021-08-18 4 Thorp Clay PHAS Common Stock P - Purchase D 3,0000 10.000 30 32.943
2021-08-04 2021-08-03 4 Sharp John P PHAS Common Stock A - Award D 1,6800 7.500 13 50.224
2021-07-14 2021-07-12 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 1,7400 4.519 8 27.760
2021-06-04 2021-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-05-24 2021-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2,8000 5.257 15 23.241
2021-05-24 2021-05-20 4 York Michael PHAS Common Stock A - Award D 2,8000 2.897 8 7.059
2021-05-24 2021-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 2,8000 1.088 3 2.087
2021-05-24 2021-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 2,8000 3.964 11 126.850
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock S - Sale D 3,2900 -3.811 -13 0
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 2,8000 3.811 11 3.811
2021-05-24 2021-05-20 4 Sharp John P PHAS Common Stock A - Award D 2,8000 1.419 4 42.724
2021-02-09 2021-02-05 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 4,31 234.000 234.000
2021-02-09 2021-02-05 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2021-02-09 2021-02-05 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2021-02-09 2021-02-05 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2021-02-09 2021-02-05 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 4,31 76.500 76.500
2021-02-09 2021-02-05 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 4,31 76.500 76.500
2021-02-09 2021-02-05 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2020-12-04 2020-12-03 4 HARRIGAN EDMUND PHAS Common Stock P - Purchase D 4,1200 6.000 25 6.000
2020-11-24 2020-11-24 4 Thorp Clay PHAS Common Stock P - Purchase D 3,5000 2.000 7 22.943
2020-11-24 2020-11-23 4 Thorp Clay PHAS Common Stock P - Purchase D 3,6700 3.000 11 20.943
2020-11-23 2020-11-20 4 Sharp John P PHAS Common Stock A - Award D 3,0000 1.305 4 41.305
2020-11-23 2020-11-20 4 Hanson Kristopher PHAS Common Stock A - Award D 3,0000 999 3 999
2020-11-23 2020-11-20 4 York Michael PHAS Common Stock A - Award D 3,0000 2.662 8 4.162
2020-11-23 2020-11-20 4 Ballance David James PHAS Common Stock A - Award D 3,0000 919 3 8.519
2020-11-23 2020-11-20 4 Mow Jonathan P PHAS Common Stock A - Award D 3,0000 3.643 11 122.886
2020-11-23 2020-11-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 3,0000 4.832 14 17.984
2020-11-23 2020-11-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 3,4500 -3.497 -12 0
2020-11-23 2020-11-20 4 Burkhardt Glen PHAS Common Stock A - Award D 3,0000 3.497 10 3.497
2020-11-18 2020-11-16 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock J - Other I 10.586 15.432
2020-11-18 2020-11-16 4 Thorp Clay PHAS Common Stock J - Other D 2.144 17.943
2020-11-18 2020-11-16 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock J - Other I -52.397 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,15 1,1500 -5.423 -6 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,1500 5.423 6 13.152
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,15 1,1500 -5.423 -6 0
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,1500 5.423 6 7.729
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 -10.000 148.767
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 10.000 12 119.243
2020-08-17 2020-08-14 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 -5.000 105.582
2020-08-17 2020-08-14 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 5.000 8 40.000
2020-06-05 2020-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 4.909 4.909
2020-06-05 2020-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,00 16.000 16.000
2020-06-05 2020-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5,19 20.000 20.000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 5,19 100.000 100.000
2020-02-14 2020-02-12 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Sapir Alex PHAS Employee Stock Option (right to buy) A - Award D 5,19 32.000 32.000
2020-02-14 2020-02-12 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 5,19 100.000 100.000
2020-02-14 2020-02-12 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5,19 290.000 290.000
2019-10-07 2019-10-07 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4,17 66.000 66.000
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 -19.000 158.767
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 19.000 24 109.243
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,44 -5.000 4.038
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 -10.000 110.582
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1,4400 5.000 7 35.000
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 10.000 17 30.000
2019-07-03 2019-07-01 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14,0000 -459 -6 415.959
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14,0000 -255 -4 52.397
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14,0000 -180 -3 162.890
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14,0000 -2.014 -28 1.818.638
2019-06-20 2019-06-18 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14,0000 -63 -1 416.418
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14,0000 -35 -0 52.655
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14,0000 -25 -0 163.074
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14,0000 -277 -4 1.820.656
2019-05-24 2019-05-22 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 -15.000 120.582
2019-05-24 2019-05-22 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 15.000 25 20.000
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 1,24 -19.131 0
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 19.131 24 90.243
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 2,27 -19.913 0
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Common Stock M - Exercise D 2,2700 19.913 45 71.112
2019-05-13 2019-05-09 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-05-13 2019-05-09 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-05-13 2019-05-09 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 9.167 9.167
2019-05-13 2019-05-09 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 4.583 4.583
2019-05-13 2019-05-09 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 2.750 2.750
2019-05-13 2019-05-09 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-05-13 2019-05-09 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-03-01 2019-02-27 4 TUFTS LINDA PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 3,15 45.000 45.000
2019-03-01 2019-02-27 4 Hutson Nancy J PHAS Employee Stock Option (right to buy) A - Award D 3,15 8.900 8.900
2019-03-01 2019-02-27 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 3,15 100.000 100.000
2019-03-01 2019-02-27 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 8.900 8.900
2019-03-01 2019-02-27 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 3,15 100.000 100.000
2019-03-01 2019-02-27 4 Thorp Clay PHAS Employee Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 23.000 23.000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 22.000 22.000
2019-03-01 2019-02-27 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 3,15 45.000 45.000
2019-03-01 2019-02-27 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 3,15 263.000 263.000
2019-03-01 2019-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 3,15 45.000 45.000
2018-12-17 3/A Ballance David James PHAS Common Stock D 6.600
2018-12-17 2018-12-17 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 4,4600 1.000 4 1.000
2018-12-17 2018-12-13 4 Ballance David James PHAS Common Stock P - Purchase D 3,9400 1.000 4 7.600
2018-12-17 2018-12-13 4 HARRIGAN EDMUND PHAS Employee Stock Option (right to buy) A - Award D 3,65 68.966 68.966
2018-12-17 2018-12-13 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,6900 1.000 4 51.199
2018-12-13 2018-12-10 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8500 800 3 50.199
2018-12-13 2018-12-07 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8900 700 3 49.399
2018-12-11 2018-12-10 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8500 800 3 51.699
2018-12-11 2018-12-07 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8800 2.200 9 50.899
2018-12-11 2018-12-07 4 Sharp John P PHAS Common Stock P - Purchase D 3,8400 5.000 19 5.000
2018-12-11 2018-12-11 4 York Michael PHAS Common Stock P - Purchase D 3,8800 1.500 6 1.500
2018-12-06 2018-12-04 4 Thorp Clay PHAS Common Stock P - Purchase D 3,1300 4.000 13 15.799
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series D Preferred Stock C - Conversion I -1.124.301 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock C - Conversion I -437.706 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -4.349 -22 437.706
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock X - Other I 0,1200 181.190 22 442.055
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -181.190 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock C - Conversion I -3.279.627 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock S - Sale I 5,0000 -1.177 -6 3.279.627
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock X - Other I 0,1200 49.030 6 3.280.804
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 -49.030 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock P - Purchase I 5,0000 1.800.000 9.000 6.641.634
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock C - Conversion I 4.841.634 4.841.634
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock C - Conversion D -2.303 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock S - Sale D 5,0000 -3 -0 2.303
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock X - Other D 0,1200 103 0 2.306
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Warrants to Purchase Series B Preferred Stock X - Other D 0,12 -103 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Common Stock C - Conversion D 2.303 2.303
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock C - Conversion D -2.306 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock M - Exercise D 0,1200 103 0 2.306
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0,12 -103 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Common Stock C - Conversion D 2.306 2.306
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series D Preferred Stock C - Conversion I -740.337 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock C - Conversion I -1.664.217 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -2.734 -14 1.664.217
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock X - Other I 0,1200 113.891 14 1.666.951
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -113.891 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock P - Purchase I 5,0000 600.000 3.000 3.004.554
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock C - Conversion I 2.404.554 2.404.554
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226.061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24.709 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272.107 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40.420 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13.558 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149.320 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94.874 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1.044.764 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13.609 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174.699 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4.846 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3.862 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42.530 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52.690 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -994 -5 40.420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock X - Other I 0,1200 41.414 5 41.414
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -41.414 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -104 -1 13.558
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock X - Other I 0,1200 4.309 1 13.662
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -4.309 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -1.139 -6 149.320
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock X - Other I 0,1200 47.458 6 150.459
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -47.458 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -42 -0 94.874
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock X - Other I 0,1200 1.731 0 94.916
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 -1.731 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -458 -2 1.044.764
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock X - Other I 0,1200 19.061 2 1.045.222
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 -19.061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5,0000 150.000 750 416.481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266.481 266.481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4.846 4.846
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5,0000 12.487 62 163.099
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150.612 150.612
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5,0000 137.513 688 1.820.933
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1.683.420 1.683.420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52.690 52.690
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Series B Preferred Stock C - Conversion I -3.505 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock C - Conversion D -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock M - Exercise D 0,1200 310 0 310
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0,12 -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock C - Conversion I 3.505 48.699
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Common Stock C - Conversion D 310 310
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226.061 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24.709 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272.107 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40.420 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13.558 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149.320 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94.874 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1.044.764 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13.609 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174.699 0
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4.846 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3.862 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42.530 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52.690 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -994 -5 40.420
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 41.414 5 41.414
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -41.414 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -104 -1 13.558
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 4.309 1 13.662
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -4.309 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -1.139 -6 149.320
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 47.458 6 150.459
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -47.458 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -42 -0 94.874
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 1.731 0 94.916
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -1.731 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -458 -2 1.044.764
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 19.061 2 1.045.222
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -19.061 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5,0000 150.000 750 416.481
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266.481 266.481
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4.846 4.846
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5,0000 12.487 62 163.099
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150.612 150.612
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5,0000 137.513 688 1.820.933
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1.683.420 1.683.420
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52.690 52.690
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series D Preferred Stock C - Conversion I -30.334 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series D Preferred Stock C - Conversion I -6.413 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series D Preferred Stock C - Conversion I -63.688 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock C - Conversion I -22.452 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock C - Conversion I -4.746 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock C - Conversion I -47.140 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock C - Conversion I -165.395 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock C - Conversion I -34.968 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock C - Conversion I -347.250 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series AA Preferred Stock C - Conversion I -56.874 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series AA Preferred Stock C - Conversion I -12.025 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series AA Preferred Stock C - Conversion I -119.408 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -113 -1 22.452
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 4.690 1 22.565
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -4.690 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -24 -0 4.746
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 991 0 4.770
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -991 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -237 -1 47.140
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 9.847 1 47.377
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -9.847 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -81 -0 165.395
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 3.359 0 165.476
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -3.359 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -18 -0 34.968
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 710 0 34.986
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -710 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -170 -1 347.250
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 7.053 1 347.420
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -7.053 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock P - Purchase I 5,0000 6.041 30 281.096
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock C - Conversion I 275.055 275.055
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock P - Purchase I 5,0000 1.277 6 59.429
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock C - Conversion I 58.152 58.152
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock P - Purchase I 5,0000 12.682 63 590.168
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock C - Conversion I 577.486 577.486
2018-10-17 2018-10-17 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5,00 220.000 220.000
2018-10-17 3 Thorp Clay PHAS Common Stock D 23.598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23.598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23.598
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90.388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90.388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90.388
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista